Tocotrienol Squalene Composition Mitigating Dementia
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The rapid aging of the global population has led to a significant increase in dementia cases, with existing strategies failing to effectively prevent or delay its onset and progression, particularly in older adults, where cognitive impairment and white matter lesions pose major health threats.
Innovation Solution
A composition comprising a mixture of tocotrienols, tocopherols, squalene, and B vitamins, combined with a pharmaceutically acceptable carrier, which attenuates the progression of white matter lesions and possesses neuroprotective properties to prevent or mitigate dementia by reducing oxidative stress and inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing prevention strategies are used, then general health maintenance is achieved, but they fail to effectively prevent or delay dementia onset and progression
Solution Approach 1:
The patent changes the compositional parameters by formulating a specific mixture of tocotrienols (15-35%), tocopherols (3-9%), squalene (1-5%), and B vitamins (0.5-10.5%) to achieve enhanced neuroprotective effects that existing strategies lack, directly addressing the insufficient effectiveness in preventing dementia
Solution Approach 2:
The patent combines multiple vitamin components (tocotrienols, tocopherols, squalene, and B vitamins) into a composite formulation that works synergistically to provide superior dementia prevention and mitigation effects compared to single-component strategies
2Duration of action of stationary object
If population aging continues, then life expectancy increases, but dementia cases triple by 2050
Solution Approach 1:
The patent applies preliminary action by providing a preventive composition that can be administered to older adults before dementia fully develops, aiming to prevent or delay the onset and slow progression of the disease, thereby addressing the growing burden of dementia in aging populations
3Object-affected harmful factors
If white matter lesions progress, then cognitive impairment increases, but neuroprotective intervention is needed
Solution Approach 1:
The patent converts the harmful effect of oxidative stress and inflammation that cause white matter lesions into a beneficial outcome by using antioxidant and anti-inflammatory properties of tocotrienols, tocopherols, squalene, and B vitamins to reduce these harmful factors and protect cognitive function
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively delays the onset and progression of dementia by impeding the increase in white matter lesions, reducing cognitive impairment, and preserving brain function, offering a potential solution to the growing dementia crisis.
Implementation Method 1
possesses neuroprotective properties to prevent or mitigate dementia by reducing oxidative stress and inflammation
Implementation Method 2
possesses neuroprotective properties to prevent or mitigate dementia by reducing oxidative stress and inflammation
Data Source
AI summary
The present invention provides a composition for preventing or mitigating dementia in a subject comprising a mixture of tocotrienols, tocopherol, squalene and B vitamin, and a pharmaceutically acceptable carrier.